Sphenoid Sinusitis Emedicine - Sinusitis Treatment - Help is on the Way
Mayo Clinic researchers have made great strides in recent years regarding sinusitis treatment and have come up with a new therapy for chronic sufferers called topical antifungal therapy. This particular sinusitis treatment is still new and is not widely practiced. This author, a sinusitis sufferer of long standing with two painful operations under his belt, has been in contact with one of the Mayo Clinic research physicians. I was pointed to several papers and articles describing the research completed thus far, the theory behind the research, and the resulting therapy. .
Antifungals such as Amphotericin B and Itraconazole are used in this sinusitis treatment regimen. These have already been approved by the FDA for other uses, and they can be mixed by a compounding pharmacy such as Anazao to make the topical solution needed for this new therapy. Amphotericin B, for example, was only available in my local pharmacy as an injection medication. The pharmacist was not aware that it is sometimes reformulated as a topical spray for sinusitis treatment. Patients spray the antifungal into their nostrils daily. About 75% of the chronic sinus sufferers in one of the Mayo Clinic studies saw significant improvement in their conditions following this regimen. This article on Sinusitis was written with the intention of making it very memorable to its reader. Only then is an article considered to have reached it's objective.
Simple and general terms, the Mayo Clinic research showed that some people (i.e., chronic sinusitis sufferers), have a harmful immune reaction to fungi that others do not experience. The research demonstrated that fungi are present in the air and show up in the nasal mucus of just about everyone. In the noses of chronic sinus sufferers, it showed that certain types of white blood cells will attack the fungi that are present. In doing so these cells create a compound that damages nasal membranes. Once damaged, bacteria can easily enter and cause pain, inflammation and infection. Conventional sinusitis treatment often includes antibiotics to attack the bacteria. This new sinusitis treatment aims to attack the fungi instead, thus avoiding the nasal membrane damage in the first place. One drawback is that it is not easy to determine if a patient is someone whose white blood cells attack fungi in the nose or not. It is also not known why this white blood cell reaction occurs in some people and not in others.
Also contacted Accentia, the biopharmaceutical company who has obtained a license from the Mayo Foundation to produce and market medications based on the Mayo Clinic research. They informed me that they plan to market a product based on Amphotericin B, which will have the brand name SinuNase. They will start clinical trials soon, and I submitted my name as a possible participant. Apparently I would be a good candidate since I've had sinus surgeries that didn't cure my problems. Quality is better than quantity. It is of no use writing numerous pages of nonsense for the reader. Instead, it is better to write a short, and informative article on specific subjects like Therapy Sinusitis. People tend to enjoy it more.